| UniProt ID | TM165_HUMAN | |
|---|---|---|
| UniProt AC | Q9HC07 | |
| Protein Name | Transmembrane protein 165 | |
| Gene Name | TMEM165 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 324 | |
| Subcellular Localization |
Golgi apparatus membrane Multi-pass membrane protein . Golgi apparatus, trans-Golgi network membrane. Lysosome membrane. Early endosome membrane. Late endosome membrane. |
|
| Protein Description | May function as a calcium/proton transporter involved in calcium and in lysosomal pH homeostasis. Therefore, it may play an indirect role in protein glycosylation.. | |
| Protein Sequence | MAAAAPGNGRASAPRLLLLFLVPLLWAPAAVRAGPDEDLSHRNKEPPAPAQQLQPQPVAVQGPEPARVEKIFTPAAPVHTNKEDPATQTNLGFIHAFVAAISVIIVSELGDKTFFIAAIMAMRYNRLTVLAGAMLALGLMTCLSVLFGYATTVIPRVYTYYVSTVLFAIFGIRMLREGLKMSPDEGQEELEEVQAELKKKDEEFQRTKLLNGPGDVETGTSITVPQKKWLHFISPIFVQALTLTFLAEWGDRSQLTTIVLAAREDPYGVAVGGTVGHCLCTGLAVIGGRMIAQKISVRTVTIIGGIVFLAFAFSALFISPDSGF | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 40 | O-linked_Glycosylation | AGPDEDLSHRNKEPP CCCCCCCCCCCCCCC | 32.49 | OGP | |
| 73 | O-linked_Glycosylation | ARVEKIFTPAAPVHT CCEEEEECCCCCCCC | 18.58 | 55833725 | |
| 80 | O-linked_Glycosylation | TPAAPVHTNKEDPAT CCCCCCCCCCCCCCC | 48.50 | 55833731 | |
| 117 | Ubiquitination | GDKTFFIAAIMAMRY CCHHHHHHHHHHHHH | 5.93 | - | |
| 117 | Ubiquitination | GDKTFFIAAIMAMRY CCHHHHHHHHHHHHH | 5.93 | 21963094 | |
| 128 | Phosphorylation | AMRYNRLTVLAGAML HHHHCHHHHHHHHHH | 15.38 | 24043423 | |
| 135 | Ubiquitination | TVLAGAMLALGLMTC HHHHHHHHHHHHHHH | 3.36 | - | |
| 135 | Ubiquitination | TVLAGAMLALGLMTC HHHHHHHHHHHHHHH | 3.36 | 22817900 | |
| 136 | Ubiquitination | VLAGAMLALGLMTCL HHHHHHHHHHHHHHH | 6.11 | 22817900 | |
| 137 | Ubiquitination | LAGAMLALGLMTCLS HHHHHHHHHHHHHHH | 4.82 | 22817900 | |
| 141 | Phosphorylation | MLALGLMTCLSVLFG HHHHHHHHHHHHHHH | 18.48 | 24043423 | |
| 144 | Phosphorylation | LGLMTCLSVLFGYAT HHHHHHHHHHHHHHH | 20.94 | 24043423 | |
| 145 | Ubiquitination | GLMTCLSVLFGYATT HHHHHHHHHHHHHHH | 3.11 | 21890473 | |
| 145 | Ubiquitination | GLMTCLSVLFGYATT HHHHHHHHHHHHHHH | 3.11 | - | |
| 149 | Phosphorylation | CLSVLFGYATTVIPR HHHHHHHHHHHHCHH | 8.08 | 24043423 | |
| 151 | Phosphorylation | SVLFGYATTVIPRVY HHHHHHHHHHCHHHH | 17.08 | 24043423 | |
| 152 | Phosphorylation | VLFGYATTVIPRVYT HHHHHHHHHCHHHHH | 14.31 | 24043423 | |
| 163 | Phosphorylation | RVYTYYVSTVLFAIF HHHHHHHHHHHHHHH | 9.18 | - | |
| 164 | Ubiquitination | VYTYYVSTVLFAIFG HHHHHHHHHHHHHHH | 15.93 | 21890473 | |
| 164 | Ubiquitination | VYTYYVSTVLFAIFG HHHHHHHHHHHHHHH | 15.93 | - | |
| 165 | Ubiquitination | YTYYVSTVLFAIFGI HHHHHHHHHHHHHHH | 3.01 | 22817900 | |
| 165 | Ubiquitination | YTYYVSTVLFAIFGI HHHHHHHHHHHHHHH | 3.01 | - | |
| 180 | Ubiquitination | RMLREGLKMSPDEGQ HHHHHHCCCCCCCCH | 48.46 | 21906983 | |
| 181 | Sulfoxidation | MLREGLKMSPDEGQE HHHHHCCCCCCCCHH | 9.39 | 30846556 | |
| 198 | Ubiquitination | EEVQAELKKKDEEFQ HHHHHHHHHCCHHHH | 49.64 | 21906983 | |
| 199 | Ubiquitination | EVQAELKKKDEEFQR HHHHHHHHCCHHHHH | 77.43 | 22817900 | |
| 200 | Ubiquitination | VQAELKKKDEEFQRT HHHHHHHCCHHHHHH | 69.64 | 22817900 | |
| 207 | Phosphorylation | KDEEFQRTKLLNGPG CCHHHHHHHCCCCCC | 18.43 | - | |
| 208 | Ubiquitination | DEEFQRTKLLNGPGD CHHHHHHHCCCCCCC | 53.84 | 21890473 | |
| 208 | Ubiquitination | DEEFQRTKLLNGPGD CHHHHHHHCCCCCCC | 53.84 | 23000965 | |
| 218 | Phosphorylation | NGPGDVETGTSITVP CCCCCCCCCCCCCCC | 45.68 | 28857561 | |
| 220 | Phosphorylation | PGDVETGTSITVPQK CCCCCCCCCCCCCCC | 25.11 | 27251275 | |
| 221 | Phosphorylation | GDVETGTSITVPQKK CCCCCCCCCCCCCCH | 20.01 | 25159151 | |
| 223 | Phosphorylation | VETGTSITVPQKKWL CCCCCCCCCCCCHHH | 26.38 | 25627689 | |
| 227 | Ubiquitination | TSITVPQKKWLHFIS CCCCCCCCHHHHHHH | 39.59 | 21890473 | |
| 227 | Ubiquitination | TSITVPQKKWLHFIS CCCCCCCCHHHHHHH | 39.59 | 21906983 | |
| 228 | Ubiquitination | SITVPQKKWLHFISP CCCCCCCHHHHHHHH | 50.14 | 22817900 | |
| 231 | Ubiquitination | VPQKKWLHFISPIFV CCCCHHHHHHHHHHH | 19.51 | 21890473 | |
| 231 | Ubiquitination | VPQKKWLHFISPIFV CCCCHHHHHHHHHHH | 19.51 | - | |
| 253 | Phosphorylation | LAEWGDRSQLTTIVL HHHHCCHHHCCEEEE | 33.99 | - | |
| 256 | Phosphorylation | WGDRSQLTTIVLAAR HCCHHHCCEEEEEEC | 13.57 | - | |
| 267 | Phosphorylation | LAAREDPYGVAVGGT EEECCCCCCEECCCH | 36.23 | 27251275 | |
| 274 | Phosphorylation | YGVAVGGTVGHCLCT CCEECCCHHHHHHHH | 19.86 | 27251275 | |
| 281 | Phosphorylation | TVGHCLCTGLAVIGG HHHHHHHHCCCEECC | 23.45 | 27251275 | |
| 294 | Ubiquitination | GGRMIAQKISVRTVT CCHHHHHCCCCEEEE | 28.11 | 22817900 | |
| 294 | Ubiquitination | GGRMIAQKISVRTVT CCHHHHHCCCCEEEE | 28.11 | 21890473 | |
| 296 | Phosphorylation | RMIAQKISVRTVTII HHHHHCCCCEEEEEE | 16.75 | 28787133 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TM165_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TM165_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TM165_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| ARPC2_HUMAN | ARPC2 | genetic | 26472760 | |
| AT2C1_HUMAN | ATP2C1 | genetic | 26472760 | |
| UBE4B_HUMAN | UBE4B | genetic | 26472760 | |
| PPME1_HUMAN | PPME1 | genetic | 26472760 | |
| WDR62_HUMAN | WDR62 | genetic | 26472760 | |
| VPS35_HUMAN | VPS35 | genetic | 26472760 | |
| PTAR1_HUMAN | PTAR1 | genetic | 26472760 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| 614727 | Congenital disorder of glycosylation 2K (CDG2K) | |||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...